Affimed N.V. (AFMDQ)

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Antibodies	8.95M
Antibodies Growth	-79.42%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
United States	8.94M
United States Growth	-79.35%
Germany	5.41K
Germany Growth	-96.62%